Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 Next >
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags Health Care Earnings Benzinga
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags Market News IONS Stocks to Sell
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags Benzinga Health Care Biotech
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags AZN IONS Recent Press Releases
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags General IONS Price Target
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Benzinga Analyst Ratings
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags AZNCF Market News AZN
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags Briefs News Biotech
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Market News Benzinga IONS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags BEAM ORIC ARWR
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags IONS BIIB AMLX
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags BIIB Markets Market News
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags Market News Benzinga Earnings
From Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
Tickers IONS
Tags Analyst Ratings Analyst Color Market News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga Market News IONS
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
Tickers ARKG EXAS IONS PACB
Tags IONS disruptive technology channel Cologuard
From ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Market News Benzinga BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Tickers ADPT AIMC AMV APPN
Tags Benzinga SBUX RDFN
From Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers IONS
Tags BZI/ROCE IONS Market News
From Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
Tickers ALPS IONS SBIO
Tags ALPS IONS SS&C
From ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
Tickers IONS
Tags IONS BZI/AAR Analyst Ratings
From Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Tickers HCAT IONS PSX RSKD
Tags VFF Price Target Benzinga
From Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
Tickers BAYRY BAYZF IONS
Tags BAYRY Market News IONS
From Benzinga
3 Biotech Stocks to Sell in October
Tickers GILD GLPG ILMN IONS
Tags IONS NASDAQ:ILMN,NASDAQ:GLPG,NASDAQ:IONS,NASDAQ:GILD GLPG
From InvestorPlace
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
Tickers AZN AZNCF IONS
Tags AZNCF IONS General
From Benzinga
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Tickers AMLX BIIB IONS
Tags Market News Recent Press Releases IONS
From Motley Fool
There's 'Outsized' Risk-Reward For This Biotech, Morgan Stanley Says, Predicting Shares Could Grow More Than 30%
Tickers IONS
Tags Market News Analyst Ratings Trading Ideas
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Tickers ADCT ALEC ANNX ARVN
Tags ENPH Intraday Update CFVI
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR IONS Analyst Ratings
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Tickers BCYC DBVT ERAS GKOS
Tags NBTX News VRAY
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.